E

Trafficking Heme

A study led by Barry H. Paw, MD, PhD, with Yvette Y. Yien, PhD, BWH Division of Hematology, discovered…

E
TIMI Group

Thirty Years of Heart Health With TIMI

TIMI celebrates 30 years of excellence.

E
cardio

Brigham Cardiologists Present New Research at European Society of Cardiology Meeting

BWH physicians and researchers participate in the European Society of Cardiology Congress.

E
Elliott Antman and Patrick O’Gara

Leading the Way in Heart and Vascular Care From BWH’s Doorstep

It's not every day that the leaders of the two most prominent cardiology and cardiovascular organizations in the United States come from the same hospital.

E
Mary Walsh is BWH's first patient to undergo a transcatheter aortic valve replacement without general anesthesia.

BWH Performs its First Aortic Valve Replacement Without General Anesthesia

Mary Walsh is BWH's first patient to undergo a transcatheter aortic valve replacement without general anesthesia.

E
Javid Moslehi, MD, is co-director of the Cardio-Oncology Program at BWH and DFCI.

Combining Passions, Advancing Care

The Cardio-Oncology Program, a joint collaboration between BWH and Dana-Farber Cancer Institute, focuses on the cardiovascular side effects of cancer therapy while maximizing cardiovascular outcomes for cancer survivors.

E
aikawa_thumb

Researchers Identify Novel Marker and Possible Therapeutic Target for Cardiovascular Calcification

A team of researchers has discovered certain proteins in osteoclasts, a precursor to bone, that may be used in helping to destroy cardiovascular calcification by dissolving mineral deposits.

E
From left, David McCready, Sanjay Pathak, guest speaker Kim Eagle, John Byrne and Mandeep Mehra

A Vision for the Future: BWH’s Heart & Vascular Center

BWH leadership and cardiovascular staff came together Jan. 22 to celebrate the launch of BWH’s Heart & Vascular Center, a fully integrated and aligned service dedicated to delivering life-giving breakthroughs.

E

Greek and US Experts Talk Vascular Biology

An international symposium assembled at BWH to discuss heart disease.

E
John Byrne, MD, and Mandeep Mehra, MD

Cardiogenic Shock Team Provides Rapid Coordinated Response

The Center for Advanced Heart Disease at BWH is taking an innovative approach to caring for some of its sickest patients.

E
Paul M. Ridker, MD, director of the BWH Center for Cardiovascular Disease Prevention (pictured right), is leading the NIH-funded Cardiovascular Inflammation Reduction Trial with a team of BWH faculty including Samuel Z. Goldhaber, MD, director of the BWH Thrombosis Research Group (pictured left).

Novel Trial Evaluates Inflammation Reduction to Prevent Recurrent Cardiovascular Events

The Cardiovascular Inflammation Reduction Trial studies whether a drug used to treat rheumatoid arthritis can also reduce recurrent cardiovascular events.

E
Guillermo García-Cardeña

Vascular Ingenuity

Research Roundup

E
David E. Cohen

Understanding Signals

Research Roundup

E
blumberg

Novel Drug Discovery Leads to Company, Acquisition

Richard Blumberg, MD, humbly refers to his hemophilia drug discovery as “a beautiful mistake.”